Respiratory syncytial virus (RSV): Potential significant opportunity for effective vaccine

  Pioneering new research into respiratory syncytial virus (RSV) may have overcome the barriers that have impeded the development of an effective vaccine against the deadly virus. RSV is a virus that causes lower respiratory tract infections and is a major cause of childhood morbidity and mortality worldwide. Attempts to develop vaccines against the virus in the 1960s were dogged …